284 related articles for article (PubMed ID: 29402328)
1. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Melucci E; Casini B; Ronchetti L; Pizzuti L; Sperati F; Pallocca M; De Nicola F; Goeman F; Gallo E; Amoreo CA; Sergi D; Terrenato I; Vici P; Di Lauro L; Diodoro MG; Pescarmona E; Barba M; Mazzotta M; Mottolese M; Fanciulli M; Ciliberto G; De Maria R; Buglioni S; Maugeri-Saccà M
J Transl Med; 2018 Feb; 16(1):22. PubMed ID: 29402328
[TBL] [Abstract][Full Text] [Related]
2. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
[TBL] [Abstract][Full Text] [Related]
3. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-Saccà M
J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862
[TBL] [Abstract][Full Text] [Related]
4. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
J Cell Physiol; 2017 Aug; 232(8):2246-2252. PubMed ID: 27987320
[TBL] [Abstract][Full Text] [Related]
5. Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy.
Vici P; Ercolani C; Di Benedetto A; Pizzuti L; Di Lauro L; Sperati F; Terrenato I; Gamucci T; Natoli C; Di Filippo F; Botti C; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
J Exp Clin Cancer Res; 2016 Apr; 35():62. PubMed ID: 27039292
[TBL] [Abstract][Full Text] [Related]
6. High expression of TAZ indicates a poor prognosis in retinoblastoma.
Zhang Y; Xue C; Cui H; Huang Z
Diagn Pathol; 2015 Oct; 10():187. PubMed ID: 26464030
[TBL] [Abstract][Full Text] [Related]
7. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.
Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X
Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.
Buglioni S; Vici P; Sergi D; Pizzuti L; Di Lauro L; Antoniani B; Sperati F; Terrenato I; Carosi M; Gamucci T; Vincenzoni C; Mariani L; Vizza E; Venuti A; Sanguineti G; Gadducci A; Barba M; Natoli C; Vitale I; Mottolese M; De Maria R; Maugeri-Saccà M
Oncoimmunology; 2016 Jun; 5(6):e1160187. PubMed ID: 27471633
[TBL] [Abstract][Full Text] [Related]
9. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
10. Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer.
De Nicola F; Goeman F; Pallocca M; Sperati F; Pizzuti L; Melucci E; Casini B; Amoreo CA; Gallo E; Diodoro MG; Buglioni S; Mazzotta M; Vici P; Sergi D; Di Lauro L; Barba M; Pescarmona E; Ciliberto G; De Maria R; Fanciulli M; Maugeri-Saccà M
Oncogenesis; 2018 Jul; 7(7):55. PubMed ID: 30032163
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
12. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
13. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
[TBL] [Abstract][Full Text] [Related]
14. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M
Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Sundara-Rajan S; Humphries MP; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
Sci Rep; 2016 Oct; 6():35121. PubMed ID: 27713571
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats.
Sammarco A; Gomiero C; Sacchetto R; Beffagna G; Michieletto S; Orvieto E; Cavicchioli L; Gelain ME; Ferro S; Patruno M; Zappulli V
Vet Pathol; 2020 Nov; 57(6):774-790. PubMed ID: 32807036
[TBL] [Abstract][Full Text] [Related]
18. The Hippo Signaling Core Components YAP and TAZ as New Prognostic Factors in Lung Cancer.
Jiang Y; Xie WJ; Chen RW; You WW; Ye WL; Chen H; Chen WX; Xu JP
Front Surg; 2022; 9():813123. PubMed ID: 35388363
[TBL] [Abstract][Full Text] [Related]
19. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
[TBL] [Abstract][Full Text] [Related]
20. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]